The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Medications for attention-deficit/hyperactivity disorder (ADHD) have some side effects that are common, while others are more ...

Stanford University researchers have discovered why some people with attention deficit hyperactivity disorder may do well on their medicine for a while but struggle down the road.

Instead, participants said, classifying methylphenidate a schedule 6 drug “ negatively impacts on treatment adherence ”. Our medicines regulator, the South African Health Products Regulatory Authority ...

Methylphenidate is a first-line treatment for ADHD and is associated with improved sleep. However, the effect of methylphenidate on sleep outcomes depends on multiple clinical and sociodemographic ...

Methylphenidate Medication Information Learn everything you need to know about Methylphenidate-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it.

And thank you to our listeners. This has been methylphenidate versus placebo for treating fatigue in people with advanced cancer, randomized, double-blind, multicenter, placebo-controlled clinical ...

Other forms of long-acting methylphenidate include the patch form (Daytrana) or Jornay, which is unique in that it is taken at night and released by the time you wake up (in theory).

You can go with a methylphenidate to dexmethylphenidate substitution (or vice versa). That is, Ritalin (mixed methylphenidates) to Focalin (dex methylphenidate) or the reverse.

Methylphenidate is also available in long-acting tablets (Concerta) and capsules (Ritalin LA). They are released into the body over the day.

Sun Pharma has yanked one lot of 20 mg Methylphenidate Hydrochloride tablets. The 7,313 100-count bottles in lot No. AC74459 with expiration date 07/31/2024 were distributed nationwide.

Rather than improving performance and productivity, smart drugs can slow you down and make you less efficient, according to a study by Melbourne University’s Centre for Brain, Mind and Markets.